These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28533100)

  • 1. Effects of Remote Ischaemic Conditioning on Heart Rate Variability and Cardiac Function in Patients With Mild Ischaemic Heart Failure.
    Chen L; Zhou Q; Jin H; Zhu K; Zhi H; Chen Z; Ma G
    Heart Lung Circ; 2018 Apr; 27(4):477-483. PubMed ID: 28533100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Vanezis AP; Arnold JR; Rodrigo G; Lai FY; Debiec R; Nazir S; Khan JN; Ng LL; Chitkara K; Coghlan JG; Hetherington SL; McCann GP; Samani NJ
    Heart; 2018 Dec; 104(23):1955-1962. PubMed ID: 29748420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term remote ischemic conditioning in patients with chronic ischemic heart failure.
    Pryds K; Nielsen RR; Jorsal A; Hansen MS; Ringgaard S; Refsgaard J; Kim WY; Petersen AK; Bøtker HE; Schmidt MR
    Basic Res Cardiol; 2017 Oct; 112(6):67. PubMed ID: 29071437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI).
    Gaspar A; Lourenço AP; Pereira MÁ; Azevedo P; Roncon-Albuquerque R; Marques J; Leite-Moreira AF
    Basic Res Cardiol; 2018 Mar; 113(3):14. PubMed ID: 29516192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans.
    Hoole SP; Khan SN; White PA; Heck PM; Kharbanda RK; Densem CG; Clarke SC; Shapiro LM; Schofield PM; O'Sullivan M; Dutka DP
    Eur J Heart Fail; 2009 May; 11(5):497-505. PubMed ID: 19386814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote ischemic conditioning improves coronary microcirculation in healthy subjects and patients with heart failure.
    Kono Y; Fukuda S; Hanatani A; Nakanishi K; Otsuka K; Taguchi H; Shimada K
    Drug Des Devel Ther; 2014; 8():1175-81. PubMed ID: 25210440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.
    Hausenloy DJ; Kharbanda RK; Møller UK; Ramlall M; Aarøe J; Butler R; Bulluck H; Clayton T; Dana A; Dodd M; Engstrom T; Evans R; Lassen JF; Christensen EF; Garcia-Ruiz JM; Gorog DA; Hjort J; Houghton RF; Ibanez B; Knight R; Lippert FK; Lønborg JT; Maeng M; Milasinovic D; More R; Nicholas JM; Jensen LO; Perkins A; Radovanovic N; Rakhit RD; Ravkilde J; Ryding AD; Schmidt MR; Riddervold IS; Sørensen HT; Stankovic G; Varma M; Webb I; Terkelsen CJ; Greenwood JP; Yellon DM; Bøtker HE;
    Lancet; 2019 Oct; 394(10207):1415-1424. PubMed ID: 31500849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction.
    Yamaguchi T; Izumi Y; Nakamura Y; Yamazaki T; Shiota M; Sano S; Tanaka M; Osada-Oka M; Shimada K; Miura K; Yoshiyama M; Iwao H
    Int J Cardiol; 2015 Jan; 178():239-46. PubMed ID: 25464262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.
    Sloth AD; Schmidt MR; Munk K; Kharbanda RK; Redington AN; Schmidt M; Pedersen L; Sørensen HT; Bøtker HE;
    Eur Heart J; 2014 Jan; 35(3):168-75. PubMed ID: 24031025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial.
    Lukhna K; Hausenloy DJ; Ali AS; Bajaber A; Calver A; Mutyaba A; Mohamed AA; Kiggundu B; Chishala C; Variava E; Elmakki EA; Ogola E; Hamid E; Okello E; Gaafar I; Mwazo K; Makotoko M; Naidoo M; Abdelhameed ME; Badri M; van der Schyff N; Abozaid O; Xafis P; Giesz S; Gould T; Welgemoed W; Walker M; Ntsekhe M; Yellon DM
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):299-305. PubMed ID: 34739648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term remote ischaemic conditioning on platelet function and fibrinolysis in patients with chronic ischaemic heart failure.
    Pryds K; Kristiansen J; Neergaard-Petersen S; Nielsen RR; Schmidt MR; Refsgaard J; Kristensen SD; Bøtker HE; Hvas AM; Grove EL
    Thromb Res; 2017 May; 153():40-46. PubMed ID: 28319824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure.
    Kjaer A; Hildebrandt P; Appel J; Petersen CL
    Int J Cardiol; 2005 Mar; 99(2):301-6. PubMed ID: 15749191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive pulmonary transit time: A new parameter for general cardiac performance.
    de Lepper AGW; Herold IHF; Saporito S; Bouwman RA; Mischi M; Korsten HHM; Reesink KD; Houthuizen P
    Echocardiography; 2017 Aug; 34(8):1138-1145. PubMed ID: 28600804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure.
    van Bommel RJ; van Rijnsoever E; Borleffs CJ; Delgado V; Marsan NA; Bertini M; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Oct; 106(8):1146-51. PubMed ID: 20920655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of the myocardial performance (Tei) index in patients with chronic heart failure].
    Larina VN; Bart BIu; Dergunova EN; Alekhin MN
    Kardiologiia; 2013; 53(11):37-44. PubMed ID: 24654433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction.
    Lachowska K; Bellwon J; Narkiewicz K; Gruchała M; Hering D
    Clin Res Cardiol; 2019 Jan; 108(1):48-60. PubMed ID: 29943271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Remote Ischaemic Conditioning on Beat-to-Beat Heart Rate Variability Circadian Rhythm in Healthy Adults.
    Qu Y; Liu J; Guo ZN; Zhang PD; Yan XL; Zhang P; Qi S; Yang Y
    Heart Lung Circ; 2021 Apr; 30(4):531-539. PubMed ID: 33032892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term remote ischemic conditioning on inflammation and cardiac remodeling.
    Pryds K; Rahbek Schmidt M; Bjerre M; Thiel S; Refsgaard J; Bøtker HE; Drage Østgård R; Ranghøj Nielsen R
    Scand Cardiovasc J; 2019 Aug; 53(4):183-191. PubMed ID: 31117835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.